Literature DB >> 19809377

Hyperoxia exposure alters hepatic eicosanoid metabolism in newborn mice.

Lynette K Rogers1, Trent E Tipple, Rodney D Britt, Stephen E Welty.   

Abstract

Prematurely born infants are often treated with supraphysiologic amounts of oxygen, which is associated with lung injury and the development of diseases such as bronchopulmonary dysplasia. Complimentary responses between the lung and liver during the course of hyperoxic lung injury have been studied in adult animals, but little is known about this relationship in neonates. These studies tested the hypothesis that oxidant stress occurs in the livers of newborn mice in response to continuous hyperoxia exposure. Greater levels of glutathione disulfide and nitrotyrosine were detected in lung tissues but not liver tissues from newborn mice exposed to hyperoxia than in room air-exposed controls. However, early increases in 5-lipoxygenase and cyclooxygenases-2 protein levels and increases in total hydroxyeicosatetraenoic acid and prostaglandin levels were observed in the liver tissues of hyperoxia-exposed pups. These studies indicate that free radical oxidation occurs in the lungs of newborn pups exposed to hyperoxia, and alterations in lipid metabolism could be a primary response in the liver tissues. The findings of this study identify possible new mechanisms associated with hyperoxic lung injury in a newborn model of bronchopulmonary dysplasia and thus open opportunities for research.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19809377      PMCID: PMC3752679          DOI: 10.1203/PDR.0b013e3181c2df4f

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  25 in total

Review 1.  Mechanisms initiating lung injury in the preterm.

Authors:  A H Jobe; M Ikegami
Journal:  Early Hum Dev       Date:  1998-11       Impact factor: 2.079

2.  Mitochondrial thiol status in the liver is altered by exposure to hyperoxia.

Authors:  Y L Wong; C V Smith; H W McMicken; L K Rogers; S E Welty
Journal:  Toxicol Lett       Date:  2001-09-15       Impact factor: 4.372

3.  Prenatal development of lung antioxidant enzymes in four species.

Authors:  L Frank; I R Sosenko
Journal:  J Pediatr       Date:  1987-01       Impact factor: 4.406

4.  Induction and decline of hepatic cytochromes P4501A1 and 1A2 in rats exposed to hyperoxia are not paralleled by changes in glutathione S-transferase-alpha.

Authors:  B Moorthy; U T Nguyen; S Gupta; K D Stewart; S E Welty; C V Smith
Journal:  Toxicol Lett       Date:  1997-01-15       Impact factor: 4.372

5.  Regulation of pulmonary and hepatic cytochrome P4501A expression in the rat by hyperoxia: implications for hyperoxic lung injury.

Authors:  Xanthi I Couroucli; Stephen E Welty; Robert S Geske; Bhagavatula Moorthy
Journal:  Mol Pharmacol       Date:  2002-03       Impact factor: 4.436

Review 6.  Mechanisms of pulmonary vascular complications of liver disease: hepatopulmonary syndrome.

Authors:  Michael B Fallon
Journal:  J Clin Gastroenterol       Date:  2005-04       Impact factor: 3.062

7.  Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates.

Authors:  P Groneck; B Götze-Speer; M Oppermann; H Eiffert; C P Speer
Journal:  Pediatrics       Date:  1994-05       Impact factor: 7.124

8.  Oxygen toxicity in neonatal and adult animals of various species.

Authors:  L Frank; J R Bucher; R J Roberts
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1978-11

9.  Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants.

Authors:  Rose M Viscardi; Catherine K Muhumuza; Andres Rodriguez; Karen D Fairchild; Chen-Chih J Sun; George W Gross; Andrew B Campbell; P David Wilson; Lisa Hester; Jeffrey D Hasday
Journal:  Pediatr Res       Date:  2004-06       Impact factor: 3.756

10.  Effects of peroxynitrite on isolated cardiac trabeculae: selective impact on myofibrillar energetic controllers.

Authors:  Michael J Mihm; Fushun Yu; Peter J Reiser; John Anthony Bauer
Journal:  Biochimie       Date:  2003-06       Impact factor: 4.079

View more
  10 in total

1.  Disruption of cytochrome P4501A2 in mice leads to increased susceptibility to hyperoxic lung injury.

Authors:  Lihua Wang; Krithika Lingappan; Weiwu Jiang; Xanthi I Couroucli; Stephen E Welty; Binoy Shivanna; Roberto Barrios; Gangduo Wang; M Firoze Khan; Frank J Gonzalez; L Jackson Roberts; Bhagavatula Moorthy
Journal:  Free Radic Biol Med       Date:  2015-02-10       Impact factor: 7.376

2.  Prenatal administration of the cytochrome P4501A inducer, Β-naphthoflavone (BNF), attenuates hyperoxic lung injury in newborn mice: implications for bronchopulmonary dysplasia (BPD) in premature infants.

Authors:  Xanthi I Couroucli; Yan-hong Wei Liang; Weiwu Jiang; Lihua Wang; Roberto Barrios; Peiying Yang; Bhagavatula Moorthy
Journal:  Toxicol Appl Pharmacol       Date:  2011-06-26       Impact factor: 4.219

3.  Metallothionein-induced zinc partitioning exacerbates hyperoxic acute lung injury.

Authors:  Sang-Min Lee; Joseph N McLaughlin; Daniel R Frederick; Lin Zhu; Kalidasan Thambiayya; Karla J Wasserloos; Iris Kaminski; Linda L Pearce; Jim Peterson; Jin Li; Joseph D Latoche; Octavia M Peck Palmer; Donna Beer Stolz; Cheryl L Fattman; John F Alcorn; Tim D Oury; Derek C Angus; Bruce R Pitt; A Murat Kaynar
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-12-28       Impact factor: 5.464

4.  Maternal docosahexaenoic acid supplementation decreases lung inflammation in hyperoxia-exposed newborn mice.

Authors:  Lynette K Rogers; Christina J Valentine; Michael Pennell; Markus Velten; Rodney D Britt; Kelly Dingess; Xuilan Zhao; Stephen E Welty; Trent E Tipple
Journal:  J Nutr       Date:  2010-12-22       Impact factor: 4.798

5.  Deficits in lung alveolarization and function after systemic maternal inflammation and neonatal hyperoxia exposure.

Authors:  Markus Velten; Kathryn M Heyob; Lynette K Rogers; Stephen E Welty
Journal:  J Appl Physiol (1985)       Date:  2010-03-11

6.  Umbilical cord blood metabolomics reveal distinct signatures of dyslipidemia prior to bronchopulmonary dysplasia and pulmonary hypertension.

Authors:  Michael R La Frano; Johannes F Fahrmann; Dmitry Grapov; Theresa L Pedersen; John W Newman; Oliver Fiehn; Mark A Underwood; Karen Mestan; Robin H Steinhorn; Stephen Wedgwood
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-08-16       Impact factor: 5.464

7.  Differences in clinical and laboratory biomarkers for short and long-term respiratory outcomes in preterm neonates.

Authors:  Richard B Parad; Janis L Breeze; Norma Terrin; Lynette K Rogers; Carolyn M Salafia; Anne Greenough; Jonathan M Davis
Journal:  Pediatr Pulmonol       Date:  2021-08-26

8.  Mice deficient in the gene for cytochrome P450 (CYP)1A1 are more susceptible than wild-type to hyperoxic lung injury: evidence for protective role of CYP1A1 against oxidative stress.

Authors:  Krithika Lingappan; Weiwu Jiang; Lihua Wang; Gangduo Wang; Xanthi I Couroucli; Binoy Shivanna; Stephen E Welty; Roberto Barrios; M Firoze Khan; Daniel W Nebert; L Jackson Roberts; Bhagavatula Moorthy
Journal:  Toxicol Sci       Date:  2014-06-03       Impact factor: 4.849

9.  Postnatal hyperoxia exposure differentially affects hepatocytes and liver haemopoietic cells in newborn rats.

Authors:  Guya Diletta Marconi; Susi Zara; Marianna De Colli; Valentina Di Valerio; Monica Rapino; Patrizia Zaramella; Arben Dedja; Veronica Macchi; Raffaele De Caro; Andrea Porzionato
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

Review 10.  Oxygen toxicity: cellular mechanisms in normobaric hyperoxia.

Authors:  Ricardo Alva; Maha Mirza; Adam Baiton; Lucas Lazuran; Lyuda Samokysh; Ava Bobinski; Cale Cowan; Alvin Jaimon; Dede Obioru; Tala Al Makhoul; Jeffrey A Stuart
Journal:  Cell Biol Toxicol       Date:  2022-09-16       Impact factor: 6.819

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.